1. Home
  2. SPG vs ZTS Comparison

SPG vs ZTS Comparison

Compare SPG & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Simon Property Group Inc.

SPG

Simon Property Group Inc.

HOLD

Current Price

$184.89

Market Cap

58.1B

Sector

Real Estate

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$126.83

Market Cap

53.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPG
ZTS
Founded
1960
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.1B
53.9B
IPO Year
1993
2013

Fundamental Metrics

Financial Performance
Metric
SPG
ZTS
Price
$184.89
$126.83
Analyst Decision
Hold
Buy
Analyst Count
14
11
Target Price
$189.07
$174.60
AVG Volume (30 Days)
1.3M
5.9M
Earning Date
02-03-2026
02-12-2026
Dividend Yield
4.76%
1.67%
EPS Growth
N/A
11.64
EPS
6.87
5.94
Revenue
$6,155,275,000.00
$9,397,000,000.00
Revenue This Year
N/A
$3.04
Revenue Next Year
$4.30
$4.98
P/E Ratio
$26.93
$21.37
Revenue Growth
4.17
2.68
52 Week Low
$136.34
$115.25
52 Week High
$190.14
$177.40

Technical Indicators

Market Signals
Indicator
SPG
ZTS
Relative Strength Index (RSI) 51.56 55.00
Support Level $182.00 $123.96
Resistance Level $187.70 $131.13
Average True Range (ATR) 2.66 2.64
MACD -0.29 0.61
Stochastic Oscillator 41.84 58.44

Price Performance

Historical Comparison
SPG
ZTS

About SPG Simon Property Group Inc.

Simon Property Group is the largest retail real estate investment trust in the United States. Its portfolio includes an interest in 254 properties: 114 traditional malls, 108 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and 12 other retail properties. Simon's portfolio averaged $736 in sales per square foot over the trailing 12 months. The company also owns a 22% interest in Klépierre, a European retail company with investments in shopping centers in 14 countries, and joint-venture interests in 33 premium outlets across 14 countries.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: